Livers of MASLD Patients End Up Less Fatty With Novel Injectable
(MedPage Today) — WASHINGTON — A large percentage of people with metabolic dysfunction-associated steatotic liver disease (MASLD) had their liver fat content normalize with an investigational dual agonist of the GLP-1 and glucagon receptors…
Patients With Colon Cancer May See Extra GLP-1 Benefits
Medications like Wegovy and Ozempic, known for managing diabetes and promoting weight loss, may also be linked to significantly lower death rates in colon cancer patients, according to a new study cited by the Independent . Researchers at UC San Diego reviewed medical records for more than 6,800 colon cancer…
Why Tracking Could Still Help on GLP-1s—Even When You’re Not Hungry
Feeling less hungry on GLP-1 medications may make tracking feel difficult. When portions shrink, cravings quiet down, and the scale moves without much effort, it’s easy to assume you have it covered. The catch is that lower appetite can also mean missed protein, too little fiber, not enough fluids, and fewer vitamins and minerals (1). […]
Pharmaceuticals, Vol. 18, Pages 1726: Potential Implications of Body Mass Composition Changes in Heart Failure Patients in the Era of SGLT2i, GLP-1 RA, and GIP/GLP-1 RA
Pharmaceuticals, Vol. 18, Pages 1726: Potential Implications of Body Mass Composition Changes in Heart Failure Patients in the Era of SGLT2i, GLP-1 RA, and GIP/GLP-1 RA Pharmaceuticals doi: 10.3390/ph18111726 Authors: Katarzyna Gryglewska-Wawrzak Agnieszka Kapłon-Cieślicka Agnieszka Pawlak Anna Tomaszuk-Kazberuk Paweł Rubiś Jacek Niedziela Agata Bielecka-Dąbrowa Obesity is a complex, multifactorial disease wherein the excessive accumulation of […]
Zealand hits pause on dual GLP-1/GLP-2 asset as CMO cites ‘increasingly crowded’ metabolic development scene
Zealand is pausing development on its dual GLP-1/GLP-2 agonist, known as dapiglutide, as it strives to focus its time and money on “programs with the greatest potential for clinical differentiation and long-term value creation,” the company said in an earnings announcement.
Weight-loss drugs linked to dramatically lower death rates in colon cancer patients
GLP-1 receptors – the drugs behind Ozempic and Mounjaro – could have great benefits for colon cancer patients, the study suggests
Is Medical Weight Loss Right for You? Finding Your Solution in Fort Lauderdale
Living in Fort Lauderdale means being surrounded by water, sunshine, and a lifestyle that often revolves around activity and looking your best. But what happens when traditional diets and endless trips to the gym aren’t producing the health results you need? For many, the struggle to achieve and maintain a healthy weight is less about […]
Zealand pauses development of GLP-1/GLP-2 obesity candidate
Zealand Pharma said Thursday it has paused one of its assets for obesity. The GLP-1/GLP-2 dual agonist dapiglutide had completed an investigator-led Phase 2 trial and was slated to begin another under Zealand’s direction. …
Opinion: This era of weight loss drugs requires a new kind of health platform
President Trump’s recently announced deal with Eli Lilly and Novo Nordisk will likely widen GLP-1 access, lowering prices for self-pay users and capping Medicare copays. Effects on commercial plans will vary by insurer, and Medicaid coverage will be determined state by state. The question now is how to best serve the millions who, freed from […]
Ozempic and tight food budgets are giving way to the giant rise of tiny foods
Getty Images; Rebecca Zisser/BI God forbid I ever say no to free food, and so the other day, I found myself breakfasting on a friend’s abandoned protein bar that I decided it was my personal mission to save from the trash. The protein bar tasted as fine as a protein bar can, but it was […]